Gibela Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Gibela Therapeutics General Information

Description

Developer of ribonucleic acid-based therapeutics designed to treat liver diseases by targeting mitochondrial dysfunction and endoplasmic reticulum stress. The company modulates key cellular pathways implicated in liver pathogenesis, enabling pharmaceutical businesses to pursue personalized approaches for common and rare liver conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Spalentorweg 31
  • 4051 Basel
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Spalentorweg 31
  • 4051 Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gibela Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 02-Apr-2025 Completed Startup
1. Spin-Off Completed Startup
To view Gibela Therapeutics’s complete valuation and funding history, request access »

Gibela Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
BaseLaunch Accelerator/Incubator Minority
To view Gibela Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Gibela Therapeutics FAQs

  • When was Gibela Therapeutics founded?

    Gibela Therapeutics was founded in 2024.

  • Where is Gibela Therapeutics headquartered?

    Gibela Therapeutics is headquartered in Basel, Switzerland.

  • What industry is Gibela Therapeutics in?

    Gibela Therapeutics’s primary industry is Drug Discovery.

  • Is Gibela Therapeutics a private or public company?

    Gibela Therapeutics is a Private company.

  • What is Gibela Therapeutics’s current revenue?

    The current revenue for Gibela Therapeutics is .

  • Who are Gibela Therapeutics’s investors?

    BaseLaunch has invested in Gibela Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process